23:46 GMT15 June 2021
Listen Live
    Get short URL

    MOSCOW (Sputnik) - Angola registered Russian single-dose coronavirus vaccine Sputnik Light, the Russian Direct Investment Fund (RDIF) said on Wednesday.

    "The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Republic of Angola," the fund said.

    In this handout photo released by Russian Direct Investment Fund, a view shows a fridge with packages of Russian Sputnik-Light one-dose vaccine against the coronavirus disease (COVID-19) developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology during clinical trials, in Moscow, Russia.
    © RIA Novosti . Russian Direct Investment Fund (RDIF)
    The Sputnik Light vaccine is the first component of the Sputnik V vaccine. The effectiveness of the single-component vaccine is 79.4 percent in the period after 28 days from inoculation.

    The calculation of effectiveness was carried out on the basis of data from Russians who received only one injection as part of the civilian mass vaccination program and did not receive a second injection for any reason between 5 December 2020 and 15 April 2021. The efficacy of about 80 percent exceeds that of many two-shot vaccines.

    In March, Angola registered the two-dose vaccine Sputnik V under an emergency use authorisation (EUA). Sputnik V has been approved for use in 64 countries with a total population of over 3.2 billion.

    vaccination, COVID-19, Angola, Russia
    Community standardsDiscussion